Status:
UNKNOWN
Natural Cycle or Stimulated Cycle Versus Hormone Replaced Cycle for Pre-eclampsia Rate
Lead Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Recent sutdies indicate that the existence of corpus lutein in the ovary is a key point to prevent preeclampsia, and patients undergoing FET with hormone replaced cycle have no corpus lutein and the a...
Eligibility Criteria
Inclusion
- 18 to 42 years old women;
- normal ovulation;
- Scheduled to undergo frozen-thawed embryo transfer.
- Agreeing with the informed consent.
Exclusion
- Those who experienced embryo transfer cycle failure for at least three times;
- One or both of the ovaries removed;
- Hypertention disease before embryo transfer;
- No available embryo for transfer
- Oocyte or sperm donated cycles
Key Trial Info
Start Date :
November 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 10 2022
Estimated Enrollment :
840 Patients enrolled
Trial Details
Trial ID
NCT04310683
Start Date
November 10 2020
End Date
March 10 2022
Last Update
March 17 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.